ARCHIVES

Research Program For Biological Response Modifiers Outlined By DCT board Subcommittee

This article is from The Cancer Letter archive.

Vol. 05 No. 46 | November 16, 1979

Download PDF Visit The Full Archive

Related Articles

In Brief: Bruce Chamber Is DeVita’s Choice as Permanent Director Of DCT; Six New RCDAs Funded In FY 1982

June 11, 1982

NCI, Canary Foundation Fund Biomarker Studies In Lung Cancer Of Never-Smokers

May 8, 2009

In Brief: Dmitrovsky Named Provost at MD Anderson; Paulsen Leaves To Chair Duke Radiology

April 12, 2013

More Than 3,000 Letters If Intent Sent To army For Breast Programs

September 10, 1993

“What Is Good For NCI Is Good For NIH,” Broder Says In Address

January 13, 1995

A History of NCCN

January 13, 2012